BeOne Medicines
ONC
#637
Rank
โ‚น3.295 T
Marketcap
โ‚น29,777
Share price
-1.91%
Change (1 day)
76.57%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

BeOne Medicines (ONC) - Total assets

Total assets on the balance sheet as of September 2025 : โ‚น685.81 Billion

According to BeOne Medicines's latest financial reports the company's total assets are โ‚น685.81 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

BeOne Medicines - Total assets on balance sheet (from 2014 to 2025)

Total assets by year

Year Total assets Change
2024-12-31โ‚น507.93 B5.1%
2023-12-31โ‚น483.28 B-8.45%
2022-12-31โ‚น527.88 B-16.91%
2021-12-31โ‚น635.30 B55.1%
2020-12-31โ‚น409.60 B256.26%
2019-12-31โ‚น114.97 B-26.91%
2018-12-31โ‚น157.30 B135.42%
2017-12-31โ‚น66.81 B142.3%
2016-12-31โ‚น27.57 B255.39%
2015-12-31โ‚น7.75 B128.33%
2014-12-31โ‚น3.39 B366.25%
2013-12-31โ‚น0.72 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Onconova Therapeutics
ONTX
โ‚น1.63 B-99.76%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
โ‚น179.30 B-73.86%๐Ÿ‡บ๐Ÿ‡ธ USA